He is an Independent Director at Danaher Corporation, and The Medicines Co.

Hugin serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA) and served as its chairman from April 2013 - April 2014. Hugin Appointed to Allergan Board of Directors - Sixth New Director Since 2017 as Part of Allergan's Transformation from a Generic to a Branded Biopharmaceutical Company - Company to.

Since 2016, he has helped build companies that combine disruptive business. During his tenure as CEO, Celgene achieved unprecedented growth and became a leading global biopharmaceutical company.ДЇrom 1985 to April 1999, Hugin worked at J.P. Sam Cole is the Managing Principal and co-founder of Stonecutter Ventures LLC. In 2013, Hugin was named the Best CEO in Biotech by the. Hugin to Danaher Board Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has appointed Robert J. Hugin first came to Celgene in June 1999 as Senior Vice President and CFO and he was elected to Celgene's Board of Directors in December 2001. Danaher Announces Appointment of Robert J. In June 2011, he was elected Chairman of the Celgene Board of Directors. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period. Hugin became the CEO of Celgene Corporation in June 2010 after already serving as Celgene's President and COO from May 2006. Executive Chairman Oncology Celgene Hong Kong.

Robert j. hugin